Mark James

442 total citations
15 papers, 372 citations indexed

About

Mark James is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Mark James has authored 15 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Mark James's work include Respiratory and Cough-Related Research (9 papers), Asthma and respiratory diseases (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Mark James is often cited by papers focused on Respiratory and Cough-Related Research (9 papers), Asthma and respiratory diseases (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Mark James collaborates with scholars based in United Kingdom, Japan and Sweden. Mark James's co-authors include Bo Lundbäck, Christine Jenkins, C. A. Pasternak, Ann J. Woolcock, Pekka Saarelainen, Anne Lindberg, P.W. Ind, Ann-Christin Jonsson, Roberto Negro and Neil Colman and has published in prestigious journals such as Brain Research, Journal of Cellular Physiology and Biochemical Society Transactions.

In The Last Decade

Mark James

15 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark James United Kingdom	11	292	267	43	19	19	15	372
J S Mann United Kingdom	9	163 0.6×	137 0.5×	44 1.0×	15 0.8×	3 0.2×	16	290
Ewa Sozańska Poland	8	308 1.1×	122 0.5×	52 1.2×	27 1.4×	5 0.3×	18	498
Akihiro Fu Japan	5	197 0.7×	261 1.0×	41 1.0×	25 1.3×	10 0.5×	14	345
Paula Pinto Portugal	12	227 0.8×	238 0.9×	128 3.0×	30 1.6×	9 0.5×	42	461
Matthew Harvey United Kingdom	7	96 0.3×	77 0.3×	20 0.5×	7 0.4×	4 0.2×	10	178
Kaninika Basu United Kingdom	8	206 0.7×	146 0.5×	40 0.9×	27 1.4×	1 0.1×	18	292
Amir Hakim United Kingdom	6	125 0.4×	88 0.3×	51 1.2×	9 0.5×	4 0.2×	13	322
Anne Pottier France	4	215 0.7×	144 0.5×	13 0.3×	16 0.8×	2 0.1×	5	279
Sven Erik Dahlén Sweden	5	190 0.7×	157 0.6×	51 1.2×	5 0.3×	1 0.1×	5	251
Yasuji Arimura Japan	9	99 0.3×	116 0.4×	52 1.2×	40 2.1×	8 0.4×	24	334

Countries citing papers authored by Mark James

Since Specialization

Citations

This map shows the geographic impact of Mark James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark James more than expected).

Fields of papers citing papers by Mark James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark James. The network helps show where Mark James may publish in the future.

Co-authorship network of co-authors of Mark James

This figure shows the co-authorship network connecting the top 25 collaborators of Mark James. A scholar is included among the top collaborators of Mark James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark James. Mark James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Barnes, Neil, Takeo Ishii, Nobuyuki Hizawa, et al.. (2018). The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world. International Journal of COPD. Volume 13. 433–440. 11 indexed citations

Betsuyaku, Tomoko, Motokazu Kato, Keisaku Fujimoto, et al.. (2018). A randomized trial of symptom-based management in Japanese patients with COPD. International Journal of COPD. Volume 13. 2409–2423. 10 indexed citations

Gross, Annette S., et al.. (2015). Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials. BMC Pulmonary Medicine. 15(1). 165–165. 6 indexed citations

Jones, Diana, Keisaku Fujimoto, Gerry Hagan, et al.. (2013). A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011. International Journal of COPD. 8. 453–453. 9 indexed citations

Lundbäck, Bo, Eva Rönmark, Anne Lindberg, et al.. (2008). Asthma control over 3 years in a real-life study. Respiratory Medicine. 103(3). 348–355. 24 indexed citations

Lundbäck, Bo, Eva Rönmark, Anne Lindberg, et al.. (2005). Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respiratory Medicine. 100(1). 2–10. 41 indexed citations

Ind, P.W., et al.. (2003). Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma. Respiratory Medicine. 97(5). 555–562. 60 indexed citations

Juniper, Elizabeth F., Christine Jenkins, Martin Price, & Mark James. (2002). Impact of Inhaled Salmeterol/Fluticasone Propionate Combination Product versus Budesonide on the Health-Related Quality of Life of Patients with Asthma. PubMed. 1(6). 435–440. 30 indexed citations

Johansson, Gunnar, et al.. (2001). Comparison of Salmeterol/Fluticasone Propionate Combination with Budesonide in Patients with Mild-to-Moderate Asthma. Clinical Drug Investigation. 21(9). 633–642. 31 indexed citations

10.

Jenkins, Christine, Ann J. Woolcock, Pekka Saarelainen, Bo Lundbäck, & Mark James. (2000). Salmeterol/fluticasone propionate combination therapy 50/250 μ g twice daily is more effective than budesonide 800 μ g twice daily in treating moderate to severe asthma. Respiratory Medicine. 94(7). 715–723. 72 indexed citations

11.

James, Mark, et al.. (1986). The use of animal virus or shuttle vectors to characterize mutagenesis in mammalian cells.. PubMed. 209A. 411–21. 1 indexed citations

12.

Gray, Michael A., Mark James, J. C. Booth, & C. A. Pasternak. (1986). Increased sugar transport in BHK cells infected with semliki forest virus or with herpes simplex virus. Archives of Virology. 87(1-2). 37–48. 16 indexed citations

13.

Warren, Andrew P., et al.. (1986). Stress induces an increased hexose uptake in cultured cells. Journal of Cellular Physiology. 128(3). 383–388. 31 indexed citations

14.

Mayer, Mark L., Mark James, Robert John Russell, et al.. (1985). Spontaneous electrical activity induced by herpes virus infection in rat sensory neuron cultures. Brain Research. 341(2). 360–364. 29 indexed citations

15.

James, Mark & C. A. Pasternak. (1985). Hexose uptake after herpes simplex virus infection. Biochemical Society Transactions. 13(4). 696–697. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact